Comments*

 
  • Genome Integrity Discussion Group

    The greater New York Metropolitan area has become a leading center for research on chromosome biology and function, as well as for research at the interface between chromosome integrity and onset and progression of malignancy. The connection between cancer and genome integrity is widely appreciated, and the concentration of excellence in this field is unparalleled anywhere in the world. The Genome Integrity meetings are designed to provide a forum for interactions between the many basic science and clinically-oriented research groups working on these issues. We feel that these interactions will not only facilitate synergy between labs, but also provide a context in which previously unappreciated complementarities will be revealed.

    In that spirit, the talks will cover a broad range of areas, including, but not limited to the DNA damage response and cancer predisposition, DNA replication, transcription, chromatin modification, recombination, cell cycle control, telomeres, chromosome segregation, epigenetic states, as well as the emergence of new technologies relevant to research in genome integrity. Although a primary focus is upon basic mechanisms and processes, these areas are pertinent to cancer and myriad human disease states, and it is expected that this will be reflected in the substance of our discussions.

    The Genome Integrity Meetings are organized under the leadership of John Petrini (Memorial Sloan Kettering Cancer Center), and Rodney Rothstein and Lorraine Symington (Columbia University). Meetings include a scientific symposium from 2:00 to 5:30 PM, followed by a networking reception from 5:30 to 6:30 PM.

  • Events

    Monday, June 4, 2012 | 2:00 PM - 7:00 PM

    Genome Integrity Discussion Group Meeting

    Organizers: John Petrini (Memorial Sloan-Kettering Cancer Center), Rodney Rothstein (Columbia University Medical Center), Lorraine Symington (Columbia University Medical Center)
    Keynote Speaker: Susan M. Gasser (Friedrich Miescher Institute for Biomedical Research)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

  • Steering Committee

    Lorraine S. Symington, PhD

    Columbia University Medical Center

    John Petrini, PhD

    Memorial Sloan-Kettering Cancer Center

    Rodney Rothstein, PhD

    Columbia University Medical Center

     

     


  • Sponsors

    Mission Partner support for the Frontiers of Science program provided by:

    • Johnson & Johnson

    Academy Friend

    Abcam

    Get more information about how you can sponsor a discussion group.

    EmailPrint